You are here

Article Text

Article menu
Download PDFPDF
Editorial
Antithrombotic drug use: scientific breakthroughs, biological limits and physician behaviour

https://doi.org/10.1136/heartjnl-2016-309902

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests EMH has served as a scientific consultant for Armetheon, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Janssen, Medronic, Portola, Pfizer. EMH has served as a speaker in scientific symposia for Boehringer Ingelheim, Daiichi Sankyo, and Bristol Myers Squibb.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles